ELEPHAS BIOSCIENCES ANNOUNCES NEW RESEARCH PARTNERSHIP WITH THE UNIVERSITY OF LOUISVILLE TO STUDY ADVANCED STAGE SOLID CANCER TUMORS IN COLORECTAL ...

Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today a new research partnership ...
Morningstar

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY ...

MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
MobiHealthNews

Live tumor imaging company Elephas garners $55M

Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
Morningstar

ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM

MADISON, Wis., Nov. 6, 2025 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tumor profiling platform for immunotherapy response ...
Business Insider

Elephas Announces $41.5 Million in Series B Funding

Arch Venture Partners leads round to advance company's novel live tumor diagnostic platform MADISON, Wis., Sept. 6, 2022 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company, ...
MarketWatch

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY ...

The MarketWatch News Department was not involved in the creation of this content. Premal H. Patel, MD, PhD, appointed Chief Medical Officer; Dr. Michael F. Giordano joins Scientific Advisory Board ...